Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,036.06. The company's market cap stands at 981.75B, with a P/E ratio of 51.41 and a dividend yield of 57.7%.
On 2026-01-28, Eli Lilly(LLY) stock moved within a range of $1,034.84 to $1,073.39. With shares now at $1,036.06, the stock is trading +0.1% above its intraday low and -3.5% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.59M, versus its average volume of 2.82M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
The Trump administration has announced the names of 15 drugs targeted for Medicare price negotiations for 2028. The new list of branded medications announced by...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerful invest...
Thanks to its weight loss and diabetes products, the drug company has seen its shares soar. When I last wrote about Eli Lilly (LLY 2.31%) back in September, th...
Analyst ratings
77%
of 31 ratingsMore LLY News
Eli Lilly is the leader in GLP-1 weight loss drugs today, but that advantage won't last forever. If you follow the news at all, you know that GLP-1 weight loss...
Eli Lilly (NYSE:LLY) received FDA Breakthrough Therapy designation for sofetabart mipitecan for platinum resistant ovarian cancer. The company expanded its art...
Both companies may succeed in this industry. Pharmaceutical giant Eli Lilly (LLY 0.12%) and biotech Viking Therapeutics (VKTX 0.12%) have one major thing in co...
NVIDIA Just Made a Bigger Push Into AI Drug Discovery Quick Read Nvidia formed a $1B partnership with Eli Lilly to develop a co-innovation AI lab for drug disc...
Eli Lilly’s (LLY) new marketing campaign focuses on weight stigma and healthy body image. Claim 50% Off TipRanks Premium The pharmaceutical company has unveil...
This drugmaker continues to strengthen its investment thesis. Artificial intelligence (AI) isn't just a gimmick or a fad. The technology is changing the lives...
The FDA’s Breakthrough Therapy designation for Eli Lilly (LLY) candidate sofetabart mipitecan in platinum resistant ovarian cancer has pushed oncology back into...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.